| First-line anti-tuberculosis drug resistance patterns and trends at the national TB referral center in Iran—eight years of surveillance M Shamaei, M Marjani, E Chitsaz, M Kazempour, M Esmaeili, P Farnia, ... International Journal of Infectious Diseases 13 (5), e236-e240, 2009 | 113 | 2009 |
| Adverse effects of multidrug-resistant tuberculosis treatment with a standardized regimen: a report from Iran P Baghaei, P Tabarsi, D Dorriz, M Marjani, M Shamaei, MV Pooramiri, ... American journal of therapeutics 18 (2), e29-e34, 2011 | 79 | 2011 |
| Transbronchial lung biopsy: the pathologist's point of view M Pourabdollah, M Shamaei, S Karimi, M Karimi, A Kiani, HR Jabbari The clinical respiratory journal 10 (2), 211-216, 2016 | 67 | 2016 |
| Evidence for M2 macrophages in granulomas from pulmonary sarcoidosis: a new aspect of macrophage heterogeneity M Shamaei, E Mortaz, M Pourabdollah, J Garssen, P Tabarsi, A Velayati, ... Human immunology 79 (1), 63-69, 2018 | 66 | 2018 |
| Association between chronic periodontitis and serum lipid levels F Taleghani, M Shamaei, M Shamaei Acta Medica Iranica 48 (1), 47-50, 2010 | 66 | 2010 |
| Qualification study of two genomic DNA extraction methods in different clinical samples A Javadi, M Shamaei, LM Ziazi, M Pourabdollah, A Dorudinia, ... Tanaffos 13 (4), 41, 2014 | 61 | 2014 |
| Histopathological findings in immunohistological staining of the granulomatous tissue reaction associated with tuberculosis S Karimi, M Shamaei, M Pourabdollah, M Sadr, M Karbasi, A Kiani, ... Tuberculosis research and treatment 2014 (1), 858396, 2014 | 58 | 2014 |
| Pulmonary disease caused by Mycobacterium simiae in Iran’s national referral center for tuberculosis P Baghaei, P Tabarsi, P Farnia, M Marjani, FM Sheikholeslami, M Chitsaz, ... The Journal of Infection in Developing Countries 6 (01), 23-28, 2012 | 57 | 2012 |
| Tuberculosis-associated secondary pneumothorax: a retrospective study of 53 patients M Shamaei, P Tabarsi, S Pojhan, L Ghorbani, P Baghaei, M Marjani, ... Respiratory care 56 (3), 298-302, 2011 | 47 | 2011 |
| Treatment outcome, mortality and their predictors among HIV-associated tuberculosis patients P Tabarsi, E Chitsaz, A Moradi, P Baghaei, P Farnia, M Marjani, ... International journal of STD & AIDS 23 (9), e1-e4, 2012 | 46 | 2012 |
| Standardised second-line treatment of multidrug-resistant tuberculosis during pregnancy P Tabarsi, A Moradi, P Baghaei, M Marjani, M Shamaei, N Mansouri, ... The International Journal of Tuberculosis and Lung Disease 15 (4), 547-550, 2011 | 44 | 2011 |
| Nocardiosis: risk factors, clinical characteristics and outcome IA Darazam, M Shamaei, M Mobarhan, S Ghasemi, P Tabarsi, ... Iranian Red Crescent Medical Journal 15 (5), 436, 2013 | 43 | 2013 |
| Nontuberculous mycobacteria, macrophages, and host innate immune response M Shamaei, M Mirsaeidi Infection and immunity 89 (8), 2021 | 35 | 2021 |
| Impact of extensively drug-resistant tuberculosis on treatment outcome of multidrug-resistant tuberculosis patients with standardized regimen: report from Iran P Tabarsi, E Chitsaz, P Baghaei, M Shamaei, P Farnia, M Marjani, ... Microbial Drug Resistance 16 (1), 81-86, 2010 | 34 | 2010 |
| Drug abuse profile–patient delay, diagnosis delay and drug resistance pattern–among addict patients with tuberculosis M Shamaei, M Marjani, P Baghaei, E Chitsaz, E Rezaei Tabar, ... International journal of STD & AIDS 20 (5), 320-323, 2009 | 29 | 2009 |
| Drug resistance pattern and outcome of treatment in recurrent episodes of tuberculosis. M Marjani, P Baghaei, P Tabarsi, M Shamaei, D Mansouri, MR Masjedi, ... Eastern Mediterranean Health Journal 18 (9), 2012 | 28 | 2012 |
| Revised Category II regimen as an alternative strategy for retreatment of Category I regimen failure and irregular treatment cases P Tabarsi, E Chitsaz, V Tabatabaei, P Baghaei, M Shamaei, P Farnia, ... American journal of therapeutics 18 (5), 343-349, 2011 | 24 | 2011 |
| Human infections due to Mycobacterium lentiflavum: first report in Iran M Shamaei, M Marjani, P Farnia, P Tabarsi, D Mansouri Iranian journal of microbiology 2 (1), 27, 2010 | 21 | 2010 |
| The intricate expression of CC chemokines in glial tumors: evidence for involvement of CCL2 and CCL5 but not CCL11 M Moogooei, M Shamaei, H Khorramdelazad, S Fattahpour, M Moogooei, ... Acta Medica Iranica 53 (12), 770-777, 2015 | 18 | 2015 |
| Characterization of immunophenotypic aberrancies in adult and childhood acute lymphoblastic leukemia: lessons from regional variation MS Rezaei, N Esfandiari, S Refoua, M Shamaei Iranian journal of pathology 15 (1), 1, 2020 | 17 | 2020 |
Mohammad Reza MasjediProfessor of Pulmonary Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.在 sbmu.ac.ir 的电子邮件经过验证
